<ѻý>Ozempic Overdoses; Diabetes Supplement Warning; Sen. Sanders Blames Food Industryѻý> News and commentary from the endocrinology world Dec 19, 2023
<ѻý>Cannabis Exposure During Pregnancy; Tirzepatide Cessation and Weight Gainѻý> Also in TTHealthWatch: newer vaccine technologies in adults Dec 16, 2023 podcast
<ѻý>Weight-Loss Drug Overdoses; Record Number of Retracted Studies; Yoga and Cadaversѻý> Health news and commentary from around the Web gathered by ѻý staff Dec 14, 2023
<ѻý>Stopping Tirzepatide Led to Weight Gain, Trial Showsѻý> But sustained treatment kept the pounds off Dec 13, 2023
<ѻý>New Diabetes Care Standards; Near 40% Ditch T2D Meds; Zepbound Hits Shelvesѻý> News and commentary from the endocrinology world Dec 12, 2023
<ѻý>USPSTF Draft Calls for Lifestyle Shift -- Not Meds -- for Kids With Obesityѻý> Behavioral interventions should be main approach; insufficient data to back pharmacologic therapy Dec 12, 2023
<ѻý>Teens' High BMI Tied to Early Chronic Kidney Diseaseѻý> "Enormous" risk increase seen in the highest BMI categories Dec 11, 2023
<ѻý>GLP-1 Drugs Linked to Lower Colorectal Cancer Risk for Diabetes Patientsѻý> Association strongest in patients with overweight, obesity Dec 07, 2023
<ѻý>Doc Set Home on Fire? High Blood Pressure in Couples; WHO: Raise Alcohol, Soda Taxesѻý> Health news and commentary from around the Web gathered by ѻý staff Dec 06, 2023
<ѻý>Cost Hurdles Can Keep Patients From Accessing GLP-1 Receptor Agonistsѻý> Pharmacists can intervene to educate, assist with cost, two studies suggest Dec 05, 2023
<ѻý>Phase II Wins, Losses for Obesity Drugs; More Positive Veozah Data; Walking Off T2Dѻý> News and commentary from the endocrinology world Dec 04, 2023
<ѻý>Year in Review: Obesityѻý> 2023 highlights included new FDA approvals, more drugs in development, and a pivot away from BMI Dec 01, 2023
<ѻý>Mounjaro vs Ozempic for Obesity; New Microwave Ablation System; GAHT Erythrocytosisѻý> News and commentary from the endocrinology world Nov 27, 2023
<ѻý>Glucose Supplement Recalled; ADA Sued by Former Employee; Forteo Generic OK'dѻý> News and commentary from the endocrinology world Nov 21, 2023
<ѻý>Live Shingles Vaccine and Waning Immunity; Semaglutide and CV Eventsѻý> Also in TTHealthWatch: sodium and blood pressure; aspirin and LVADs Nov 18, 2023 podcast
<ѻý>Want Lower Obesity Drug Costs? Medicare Holds the Keyѻý> Medicare coverage will catalyze market competition Nov 17, 2023
<ѻý>Mall Doc Kiosks; Gaza Hospital Stormed; Rationing Semaglutide by Lifestyleѻý> Health news and commentary from around the Web gathered by ѻý staff Nov 16, 2023
<ѻý>Most Unaware of Having Prediabetes; Mid-Stage Growth Hormone Win; Fake Wegovy Woesѻý> News and commentary from the endocrinology world Nov 14, 2023
<ѻý>Double Defibrillator More Effective for Obese Afib Patientsѻý> Clinical trial affirms a better initial strategy Nov 12, 2023
<ѻý>Single-Payer Healthcare, Obesity Drug Coverage Discussed at the AMA Interim Meetingѻý> Delegates agree the current system is broken but disagree on the solution Nov 12, 2023
<ѻý>And for Wegovy's Next Trick, Full-Blown Cardiovascular Benefit Outside Diabetesѻý> Established weight loss and diabetes drug may extend reach to millions more Nov 11, 2023
<ѻý>Tirzepatide Wins FDA Approval for Weight Lossѻý> Drug also gets a new brand name, Zepbound, for its new indication Nov 08, 2023
<ѻý>Tone Matters in Weight-Loss Talks; Salt and Diabetes; Nix Brominated Veg Oil?ѻý> News and commentary from the endocrinology world Nov 07, 2023
<ѻý>Year in Review: Type 2 Diabetesѻý> New approvals, guidance on GLP-1s before surgery, and access issues led the news in 2023 Nov 01, 2023
<ѻý>Intermittent Fasting for T2D; Omnipod 5 App Cleared; GLP-1 Meds and Thyroid Cancerѻý> News and commentary from the endocrinology world Oct 31, 2023
<ѻý>Hospitalizations With Fake Ozempic; Vosoritide OK'd for All Ages; Mounjaro for Kids?ѻý> News and commentary from the endocrinology world Oct 24, 2023
<ѻý>Carbohydrates and Long-Term Weight Change; Value of Cardiac Transfersѻý> Also in TTHealthWatch: reducing infections in joint replacement Oct 21, 2023 podcast
<ѻý>Gestational Diabetes Exposure in Utero Linked to Brain Changes in Kidsѻý> These changes may contribute to an increased risk of obesity in kids, researcher says Oct 18, 2023
<ѻý>Obesity Medication Type, Insurance Carrier Linked to Treatment Persistenceѻý> Amount of weight lost by 6 months also played a role, according to a retrospective cohort study Oct 18, 2023
<ѻý>Virtual Obesity Treatment Program Led to Substantial Weight Loss in Real-World Studyѻý> At 12 months, there was an average weight loss of 16.2%, with results sustained up to 24 months Oct 17, 2023
<ѻý>Certain Factors Predict Weight Regain After Big Lossesѻý> But even "regainers" still kept off most of the weight Oct 17, 2023
<ѻý>Regaining Weight After Bariatric Surgery Did Not Lead to Excess Mortalityѻý> Weight regainers had a similar incidence of mortality as weight-loss maintainers Oct 17, 2023
<ѻý>Semaglutide's Weight-Loss Benefit Also Seen in Patients on Antidepressantsѻý> Those on antidepressants lost an average 11% to 19% of body weight across the four STEP trials Oct 16, 2023
<ѻý>Tirzepatide Has Huge Impact on Weight, Even After Loss From Lifestyle Changeѻý> Trial participants lost over a fifth of their body weight atop diet, exercise-induced losses Oct 16, 2023
<ѻý>Mental Health Warning Signs in Latinx Kids Tied to Cardiometabolic Risksѻý> Signs of depression, anxiety in middle school linked with troubles by high school Oct 16, 2023
<ѻý>Farxiga Cuts A1c in Pediatric Diabetes; Late-Stage CAH Win; At-Home Menopause Testѻý> News and commentary from the endocrinology world Oct 10, 2023
<ѻý>Time to Recognize Cardiovascular-Kidney-Metabolic Syndrome, AHA Saysѻý> Pooled cohort equations will make way for new CKM risk calculator Oct 09, 2023
<ѻý>Weight-Loss Drug Benefit Spans HFpEF, HFmrEFѻý> STEP-HFpEF trial results come out consistent across ejection fraction Oct 08, 2023
<ѻý>Adding Tirzepatide to Basal Insulin Cuts HbA1c in Poorly Controlled T2Dѻý> Results with the GIP/GLP-1 receptor agonist were statistically superior to added insulin lispro Oct 03, 2023
<ѻý>Are Obesity Drugs for Adolescents Cost-Effective?ѻý> Despite the effectiveness of these medications, costs are a major barrier Sep 30, 2023